JB
PBYI icon

Julian Baker’s Puma Biotechnology PBYI Stock Holding History

Julian Baker’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-25,000
Closed -$2.59M – 109
2013
Q4 		$2.59M Sell
25,000
-75,000
-75% -$4.4M 0.04% 77
2013
Q3 		$5.37M Buy
100,000
+16,667
+20% +$898K 0.08% 57
2013
Q2 		$3.7M Buy
+83,333
New +$2.94M 0.07% 52

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Julian Baker's PBYI Position: Q1 2014 in Review

Julian Baker sold out of Puma Biotechnology (PBYI) in Q1 2014, closing a stake of 25,000 shares — an estimated $2.59M sold.

Julian Baker first reported a position in PBYI in Q2 2013 and held it in 3 quarters. The position peaked at $5.37M in Q3 2013. 138 funds tracked by Wall St. Rank hold PBYI as of Q1 2014.

  • Julian Baker reported no remaining Puma Biotechnology position as of Q1 2014 after selling out during the quarter.
  • Julian Baker sold 25,000 Puma Biotechnology shares in Q1 2014, an estimated $2.59M.
  • Julian Baker first reported a position in Puma Biotechnology in Q2 2013 and held it in 3 quarters.
  • Julian Baker's Puma Biotechnology position peaked at $5.37M in Q3 2013.
  • 138 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2014.

Based on Baker Bros. Advisors's 13F filing for Q1 2014, filed 15 May 2014.